Riskpilot← Back to searchSign inGet full accessAquiver AB
ABActiveOrg 5591226153Bifrostvägen 3General medical practice activities · NACE 8621Est. 20171 employees
Revenue 2025
SEK 140K
-34% vs 2024
EBITDA margin
-7.7%
-121% vs 2024
Equity ratio
62.8%
Financial strength
Net profit 2025
SEK 22K
-72% vs 2024
| Revenue | SEK 140K | -34% |
| EBITDA | SEK -11K | -121% |
| Net profit | SEK 22K | -72% |
| Total assets | SEK 285K | -26% |
| Equity | SEK 179K | -21% |
| Employees | 1 | — |
Legal name
Aquiver AB
Org number
5591226153
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 augusti 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva vård samt erbjuda uthyrning av personal, företagsekonomisk konsultation och föreläsningar. Bolaget ska också äga och förvalta fast och lös egendom, samt bedriva annan med huvudverksamheten förenlig verksamhet.
Address
Bifrostvägen 3
Email
jesper.petter@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 116 | 317 | 240 | 211 | 140 |
| Staff expenses | — | −166 | −15 | −10 | −20 |
| EBITDA | 34 | 21 | 86 | 52 | −11 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 34 | 21 | 86 | 52 | −11 |
| Net financials | — | — | 1 | 0 | −0 |
| Profit before tax | 26 | 15 | 64 | 100 | 29 |
| Tax | −6 | −3 | −14 | −23 | −7 |
| Net profit | 20 | 12 | 50 | 77 | 22 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 386 | 405 | 489 | 383 | 285 |
| Equity | 227 | 239 | 290 | 227 | 179 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 5 | 7 | 19 | 22 | 13 |
| Total debt | 5 | 7 | 19 | 22 | 13 |
EBITDA margin
-7.7%
This company
15.8%
Market median
-149% vs market
20212025
Equity ratio
62.8%
This company
38.2%
Market median
+64% vs market
20212025
Return on equity
12.3%
This company
18.4%
Market median
+33% vs market
20212025
Net profit margin
15.8%
This company
8.1%
Market median
+95% vs market
20212025
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20212025
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aquiver AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tahmineh Pournouri Pettersson | Board of Directors | 0 companies |
| Erik Jesper Pettersson | Deputy Board Member | 0 companies |